Clinical Trials on NSCLC, Non-small-cell Lung Carcinoma in Denmark
Total 154 results
-
Aarhus University HospitalHoffmann-La Roche; University of Aarhus; The Ministry of Science, Technology...Unknown
-
AstraZenecaActive, not recruitingNon Small Cell Lung Carcinoma NSCLCDenmark, United Kingdom, United States, Poland, Brazil, India, Japan, Mexico, Peru, Russian Federation, Turkey, China, Malaysia, Hong Kong, Korea, Republic of, Chile, Israel, Ukraine, Portugal, Greece, Bulgaria, Philippines, Sweden, A... and more
-
Danish Lung Cancer GroupOdense University Hospital; Aarhus University Hospital; Rigshospitalet, Denmark; Herlev Hospital and other collaboratorsRecruitingRadiotherapy Side Effect | Stage IV Non-small Cell Lung Cancer | Stage III Non-small-cell Lung CancerDenmark
-
Herlev HospitalRoche Pharma AG; Bispebjerg Hospital; Copenhagen University Hospital at Herlev; Onxe...TerminatedNon Small Cell Lung CancerDenmark
-
Vejle HospitalTerminatedNon Small Cell Lung CancerDenmark
-
Herlev HospitalUniversity of CopenhagenCompleted
-
Aalborg University HospitalAarhus University HospitalCompletedCarcinoma, Non-Small-Cell Lung | Non-small-cell Lung Cancer | Lung NeoplasmDenmark
-
Rigshospitalet, DenmarkUnknownWHENII - Early Response Evaluation With FDG-PET/CT and Liquid Biopsy in Patients With NSCLC (WHENII)Non Small Cell Lung Cancer | Circulating Tumor Cell | Circulating Tumor DNADenmark
-
Rigshospitalet, DenmarkTerminatedNon-small Cell Lung CancerDenmark
-
Rigshospitalet, DenmarkUniversity of CopenhagenActive, not recruitingNon-Small Cell Lung Cancer Stage | ChemoradiationDenmark
-
University of AarhusCompletedNon-small Cell Lung Cancer PatientsDenmark
-
Rigshospitalet, DenmarkHoffmann-La RocheTerminatedNon Small Cell Lung CancerDenmark
-
Hoffmann-La RocheActive, not recruitingNon-small Cell Lung Cancer (NSCLC)United States, Korea, Republic of, Canada, Belgium, China, Denmark, Spain, Thailand, United Kingdom, Taiwan, Brazil, Germany, Mexico, Italy, Switzerland, Hong Kong, Japan, France, Turkey, New Zealand, Poland
-
Hoffmann-La RocheActive, not recruitingMetastatic Melanoma | Non-small Cell Lung Cancer (NSCLC) | Solid Tumors | Esophageal Squamous Cell Carcinoma (ESCC) | Small Cell Lung Cancer (SCLC)United States, Korea, Republic of, Denmark, France, Spain, New Zealand
-
AmgenRecruitingNon-Small Cell Lung Cancer (NSCLC)United States, Australia, Netherlands, Taiwan, Korea, Republic of, United Kingdom, Spain, Austria, Japan, Switzerland, Sweden, France, China, Czechia, Italy, Portugal, Thailand, Hong Kong, Singapore, Bulgaria, Turkey, Mexico, Argentina and more
-
Odense University HospitalAarhus University Hospital; Rigshospitalet, Denmark; Copenhagen University Hospital... and other collaboratorsCompletedNon-small Cell Lung CancerDenmark
-
The Netherlands Cancer InstituteEuropean UnionActive, not recruitingNSCLCUnited Kingdom, Denmark, Netherlands, Sweden, Belgium
-
Olfred HansenOdense University Hospital; Aarhus University Hospital; Rigshospitalet, Denmark; Copenhagen University Hospital at Herlev and other collaboratorsCompletedNon-small Cell Lung CancerDenmark
-
Merck Sharp & Dohme LLCRecruitingNon-small Cell Lung Cancer (NSCLC)China, Turkey, Australia, United States, Chile, Taiwan, Denmark, France, Spain, Argentina, Italy, Netherlands, Thailand, Korea, Republic of, Czechia, Portugal, Canada, United Kingdom
-
Vejle HospitalRecruitingLung Cancer, Non-small Cell | Lung Metastases | Radiation Toxicity | Stereotactic Body Radiation Therapy | Decision Making, SharedDenmark
-
Rigshospitalet, DenmarkCompletedSmall Cell Lung Cancer | Lung Cancer, Nonsmall CellDenmark
-
Rigshospitalet, DenmarkRecruiting
-
Rigshospitalet, DenmarkRecruitingNon-small Cell Lung Cancer | Malignant Pleural Mesothelioma | Large Cell Neuroendocrine Carcinoma of the LungDenmark
-
Rigshospitalet, DenmarkUnknownNon-Small Cell Lung CancerDenmark
-
Odense University HospitalRecruitingNon-small Cell Lung Cancer | Stereotactic Body Radiotherapy | Comprehensive Geriatric AssessmentDenmark
-
Hoffmann-La RocheTerminatedSquamous Non-Small Cell Lung CancerCanada, Spain, Denmark
-
Naestved HospitalRecruitingNon-small Cell Lung Cancer | Malignant Pleural EffusionDenmark
-
Rigshospitalet, DenmarkCompletedSmall Cell Lung Cancer | Non Small Cell Lung Cancer StageDenmark
-
Rigshospitalet, DenmarkCompletedSmall Cell Lung Cancer | Non Small Cell Lung CancerDenmark
-
University of AarhusCompletedNon-small-cell Lung Cancer | Radiation PneumonitisDenmark
-
Steen Riisgaard MortensenCompleted
-
Ethicon Endo-Surgery (Europe) GmbHCompleted
-
GlaxoSmithKlineCompletedLung Cancer, Non-Small CellDenmark, United Kingdom
-
University Hospital of North NorwayOdense University Hospital; Oslo University Hospital; Rigshospitalet, Denmark; University... and other collaboratorsActive, not recruitingNon-Small Cell Lung CancerNorway, Denmark
-
AstraZenecaActive, not recruitingNon-Small-Cell Lung CarcinomaFrance, Spain, Thailand, Belgium, Korea, Republic of, Netherlands, United States, Brazil, Japan, China, Malaysia, Taiwan, Australia, Denmark
-
Novartis PharmaceuticalsCompletedNon Small Cell Lung CancerFrance, Canada, United States, Russian Federation, Denmark
-
AmgenActive, not recruitingKRAS p, G12c Mutated /Advanced Metastatic NSCLCFinland, United States, Canada, Belgium, Spain, Korea, Republic of, Netherlands, United Kingdom, Australia, Denmark, Hungary, Sweden, Taiwan, Greece, Russian Federation, Switzerland, France, Italy, Japan, Poland, Brazil, Germany, Po...
-
Eli Lilly and CompanyCompletedNon Small Cell Lung CarcinomaBelgium, France, Germany, Portugal, Spain, Sweden, Italy, United States, Canada, Netherlands, Argentina, Australia, Austria, Brazil, Denmark, Finland, Greece, Hungary, India, Israel, Korea, Republic of, Mexico, Poland, Puerto Rico, Taiwan, Turk... and more
-
Navire Pharma Inc., a BridgeBio companyAmgenRecruitingNon Small Cell Lung Cancer | Metastatic Solid Tumor | Solid Tumor, Adult | Metastatic NSCLCSpain, Australia, France, Denmark, Greece, Italy, Netherlands
-
Symphogen A/SCompletedNSCLC | Non Small Cell Lung Cancer | Oncology | MET Gene Mutation | MET Gene AmplificationUnited States, Korea, Republic of, Denmark, Hong Kong, Taiwan, Spain
-
Bristol-Myers SquibbEli Lilly and Company; Clovis Oncology, Inc.; ExelixisWithdrawnCarcinoma, Non-small Cell Lung CancerNetherlands, Norway, Belgium, Greece, United States, Argentina, Denmark, Mexico, Poland, Romania
-
AmgenActive, not recruitingNon-small Cell Lung CancerBelgium, Spain, United States, Denmark, Sweden, France, Turkey, Italy, Germany, Netherlands
-
European Organisation for Research and Treatment...CompletedLung CancerFrance, Spain, Denmark, Italy, Austria, Germany
-
Eli Lilly and CompanyCompletedNon-Small Cell Lung CancerItaly, Germany, Spain, Sweden, Denmark
-
AstraZenecaRecruitingNSCLCChina, United States, United Kingdom, Korea, Republic of, Italy, Hungary, Spain, Vietnam, France, Brazil, Canada, Japan, Taiwan, Germany, Austria, Turkey, India, Peru, Poland, Sweden, Bulgaria, Greece, Mexico, Denmark
-
University of AarhusOdense University Hospital; Aarhus University Hospital; Aalborg University HospitalCompletedCarcinoma, Non-Small-Cell LungDenmark
-
AstraZenecaCompletedNon-Small-Cell Lung CarcinomaUnited States, Croatia, Sweden, Italy, Mexico, Spain, Turkey, Germany, Philippines, Malaysia, China, Estonia, Latvia, Hong Kong, Argentina, Belgium, Canada, Denmark, France, Indonesia, Thailand, Brazil, Switzerland, Singapore, Slovenia
-
Zealand University HospitalCompletedMetastatic Nonsmall Cell Lung CancerDenmark
-
Novartis PharmaceuticalsTerminatedNon-Small-Cell LungGermany, Spain, Belgium, Canada, Netherlands, Italy, Taiwan, Argentina, Australia, Israel, Japan, Lebanon, France, Poland, United States, Jordan, Korea, Republic of, China, Brazil, Czechia, Greece, Russian Federation, Denmark, Hungary, ... and more
-
University of Southern DenmarkOdense University Hospital; University of Copenhagen; Region of Southern Denmark and other collaboratorsActive, not recruitingQuality of Life | Venous Thromboembolism | Non-small Cell Lung Cancer | Brain MetastasesDenmark